GRK2 and cancer: Serine 153 phosphorylation (pSer153-RKIP) by protein kinase C ζ (PKCζ) has been found in some cancer types to account for the loss of RKIP activity that in turn activates MAP kinase pathway and inhibit GPCR through inhibition of G protein-coupled receptor kinase 2 (GRK2).